Literature DB >> 16097747

Sample handling for mass spectrometric proteomic investigations of human sera.

Mikkel West-Nielsen1, Estrid V Høgdall, Elena Marchiori, Claus K Høgdall, Christian Schou, Niels H H Heegaard.   

Abstract

Proteomic investigations of sera are potentially of value for diagnosis, prognosis, choice of therapy, and disease activity assessment by virtue of discovering new biomarkers and biomarker patterns. Much debate focuses on the biological relevance and the need for identification of such biomarkers while less effort has been invested in devising standard procedures for sample preparation and storage in relation to model building based on complex sets of mass spectrometric (MS) data. Thus, development of standardized methods for collection and storage of patient samples together with standards for transportation and handling of samples are needed. This requires knowledge about how sample processing affects MS-based proteome analyses and thereby how nonbiological biased classification errors are avoided. In this study, we characterize the effects of sample handling, including clotting conditions, storage temperature, storage time, and freeze/thaw cycles, on MS-based proteomics of human serum by using principal components analysis, support vector machine learning, and clustering methods based on genetic algorithms as class modeling and prediction methods. Using spiking to artificially create differentiable sample groups, this integrated approach yields data that--even when working with sample groups that differ more than may be expected in biological studies--clearly demonstrate the need for comparable sampling conditions for samples used for modeling and for the samples that are going into the test set group. Also, the study emphasizes the difference between class prediction and class comparison studies as well as the advantages and disadvantages of different modeling methods.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16097747     DOI: 10.1021/ac050253g

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  29 in total

Review 1.  Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.

Authors:  Fulvio Magni; Yuri E M Van Der Burgt; Clizia Chinello; Veronica Mainini; Erica Gianazza; Valeria Squeo; André M Deelder; Marzia Galli Kienle
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

2.  Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling.

Authors:  Srikanth Ranganathan; Anna Polshyna; Georgina Nicholl; James Lyons-Weiler; Robert Bowser
Journal:  Clin Proteomics       Date:  2006-03-01       Impact factor: 3.988

3.  Comprehensive analysis of the N and C terminus of endogenous serum peptides reveals a highly conserved cleavage site pattern derived from proteolytic enzymes.

Authors:  Fangjun Wang; Jun Zhu; Lianghai Hu; Hongqiang Qin; Mingliang Ye; Hanfa Zou
Journal:  Protein Cell       Date:  2012-07-16       Impact factor: 14.870

4.  Non-alcoholic fatty liver disease proteomics.

Authors:  Eva Rodríguez-Suárez; Antonio M Duce; Juan Caballería; Félix Martínez Arrieta; Estefanía Fernández; Carolina Gómara; Nere Alkorta; Usue Ariz; M Luz Martínez-Chantar; Shelly C Lu; Felix Elortza; José M Mato
Journal:  Proteomics Clin Appl       Date:  2010-02-03       Impact factor: 3.494

Review 5.  Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.

Authors:  M E de Noo; R A E M Tollenaar; A M Deelder; L H Bouwman
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

6.  Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.

Authors:  Dale McLerran; William E Grizzle; Ziding Feng; William L Bigbee; Lionel L Banez; Lisa H Cazares; Daniel W Chan; Jose Diaz; Elzbieta Izbicka; Jacob Kagan; David E Malehorn; Gunjan Malik; Denise Oelschlager; Alan Partin; Timothy Randolph; Nicole Rosenzweig; Shiv Srivastava; Sudhir Srivastava; Ian M Thompson; Mark Thornquist; Dean Troyer; Yutaka Yasui; Zhen Zhang; Liu Zhu; O John Semmes
Journal:  Clin Chem       Date:  2007-11-02       Impact factor: 8.327

7.  Evaluation of the variation in sample preparation for comparative proteomics using stable isotope labeling by amino acids in cell culture.

Authors:  Guoan Zhang; David Fenyö; Thomas A Neubert
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

8.  Specific Investigation of Sample Handling Effects on Protease Activities and Absolute Serum Concentrations of Various Putative Peptidome Cancer Biomarkers.

Authors:  Irene van den Broek; Rolf W Sparidans; Jan H M Schellens; Jos H Beijnen
Journal:  Clin Proteomics       Date:  2010-09-30       Impact factor: 3.988

9.  Identification a novel clinical biomarker in early diagnosis of human non-small cell lung cancer.

Authors:  Yanxia Jin; Yajun Yang; Yanting Su; Xiangdong Ye; Wei Liu; Qing Yang; Jie Wang; Xiangning Fu; Yongsheng Gong; Hui Sun
Journal:  Glycoconj J       Date:  2019-01-03       Impact factor: 2.916

10.  A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

Authors:  C E Teunissen; A Petzold; J L Bennett; F S Berven; L Brundin; M Comabella; D Franciotta; J L Frederiksen; J O Fleming; R Furlan; R Q Hintzen; S G Hughes; M H Johnson; E Krasulova; J Kuhle; M C Magnone; C Rajda; K Rejdak; H K Schmidt; V van Pesch; E Waubant; C Wolf; G Giovannoni; B Hemmer; H Tumani; F Deisenhammer
Journal:  Neurology       Date:  2009-12-01       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.